You have 9 free searches left this month | for more free features.

Nucleophosmin 1 Mutation

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

The Prevelence of IVS 1-6 [HBB:c.92 +6 T-C] Gene Mutation in

Not yet recruiting
  • Beta-Thalassemia
  • ARMS
  • (no location specified)
May 10, 2022

Advanced Solid Tumors Trial (INCB099280, adagrasib)

Not yet recruiting
  • Advanced Solid Tumors
  • (no location specified)
Sep 8, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

HIV-1-infection Trial in Saint Louis (Biktarvy Tab)

Terminated
  • HIV-1-infection
  • Biktarvy Tab
  • Saint Louis, Missouri
    Southampton Healthcare, Inc.
Jan 3, 2023

Amyotrophic Lateral Sclerosis Trial (ARO-SOD1 Injection, Placebo: ARO-aCSF1 Injection)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis
  • ARO-SOD1 Injection
  • Placebo: ARO-aCSF1 Injection
  • (no location specified)
Jul 8, 2023

Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

Recruiting
  • Recurrent IDH1/2 Mutated Glioma
  • Paris, France
    Pitie Salpetriere Hospital
Aug 29, 2022

Non Small Cell Lung Cancer Trial (HLX208+HLX10)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • HLX208+HLX10
  • (no location specified)
Nov 30, 2022

Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)

Not yet recruiting
  • Leber Hereditary Optic Neuropathy (LHON)
  • NFS-02 Injection
  • (no location specified)
Apr 6, 2023

Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

Recruiting
  • Hereditary Breast and Ovarian Cancer
    • Barcelona, Spain
      Hospital de la Santa Creu i Sant Pau
    Jun 3, 2022

    ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

    Recruiting
    • ATM Gene Mutation
    • +16 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Oct 27, 2022

    Gastric Cancer, Gastric Tumors, Gastric Adenocarcinoma Trial run by the National Cancer Institute (NCI) (Cellvizio (Registered

    Not yet recruiting
    • Gastric Cancer
    • +2 more
    • Cellvizio (Registered trademark)Real-Time In Vivo Cellular Imaging Platform with Confocal Miniprobes
    • Olympus GIF 190 endoscope
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Solid Tumor, Adult, NSCLC, Advanced Cancer Trial (Adagrasib, nab-Sirolimus)

    Not yet recruiting
    • Solid Tumor, Adult
    • +4 more
    • (no location specified)
    Apr 24, 2023

    HER2 Insertion Mutation Positive Advanced NSCLC Trial in Changsha (PD-1 Combined With Pyrotinib)

    Recruiting
    • HER2 Insertion Mutation Positive Advanced NSCLC
    • PD-1 Combined With Pyrotinib
    • Changsha, Hunan, China
      Hunan Provincal Tumor Hospital
    Mar 1, 2022

    Alzheimer's Disease Trial in Colombia (Crenezumab, Placebo)

    Active, not recruiting
    • Alzheimer's Disease
    • Armenia, Colombia
    • +3 more
    Nov 21, 2022

    Non Small Cell Lung Cancer, Solid Tumor Trial in Fairfax (BBP-398 with nivolumab)

    Recruiting
    • Non Small Cell Lung Cancer
    • Solid Tumor
    • BBP-398 with nivolumab
    • Springdale, Arkansas
    • +6 more
    Jan 27, 2023

    Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Boston, Massachusetts
    • +2 more
    Dec 21, 2022

    Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)

    Recruiting
    • Cancer
    • +6 more
    • Indianapolis, Indiana
      Indiana University Hospital / IU Simon Cancer Center
    Jan 12, 2023

    MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)

    Not yet recruiting
    • MEN1 Gene Mutation
    • Leflunomide 20 mg
    • Basel, Switzerland
      Unispital Basel
    Nov 1, 2022

    Metastatic Breast Cancer Trial (Lasofoxifene in combination with abemaciclib, Fulvestrant in combination with abemaciclib)

    Not yet recruiting
    • Metastatic Breast Cancer
    • Lasofoxifene in combination with abemaciclib
    • Fulvestrant in combination with abemaciclib
    • (no location specified)
    Jan 25, 2023

    ARID1A Gene Mutation, ATM Gene Mutation, ATR Gene Mutation Trial in United States (Olaparib)

    Recruiting
    • ARID1A Gene Mutation
    • +15 more
    • Scottsdale, Arizona
    • +4 more
    Dec 13, 2022

    Hyperekplexia in Patients With CTNNB1 Mutation

    Not yet recruiting
    • Hyperekplexia
    • CTNNB1 Gene Mutation
    • Questionnaire
    • (no location specified)
    Feb 11, 2022

    Advanced Solid Tumor, RAS Mutation, RAF Mutation Trial in Houston, Irving (ABM-168)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Houston, Texas
    • +1 more
    Apr 14, 2023

    PD-1 Antibody Plus Chemotherapy for TKI Failure Driver Gene

    Recruiting
    • Non Small Cell Lung Cancer
      • Changsha, Hunan, China
        Yongchang Zhang
      Mar 9, 2022

      Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

      Not yet recruiting
      • Metastatic Solid Tumor
      • +4 more
      • San Francisco, California
        University of California, San Francisco
      Jan 12, 2023

      Factors Influencing Cascade Testing Among Hereditary

      Recruiting
      • Breast Carcinoma
      • +8 more
      • Interview
      • +2 more
      • Birmingham, Alabama
      • +1 more
      Jun 22, 2022